SEARCH

SEARCH BY CITATION

References

  • 1
    Cates W, Jr., and American Social Health Association Panel, Estimates of the incidence and prevalence of sexually transmitted diseases in the United States, Sexually Transmitted Diseases, 1999, 26 (Suppl. 4): S27.
  • 2
    Sonenstein FL et al. Changes in sexual behavior and condom use among teenaged males: 1988 to 1995, American Journal of Public Health, 1998, 88 (6): 956959; Abma J et al., Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth, Vital and Health Statistics, 1997, Vol. 23, No. 19; and Laumann EO et al., National Health and Social Life Survey, 1992, Chicago and Ann Arbor, MI: National Opinion Research Center and Inter-University Consortium for Political and Social Research, 1995.
  • 3
    Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
  • 1
    4.Centers for Disease Control and Prevention (CDC), Sexually Transmitted Disease Surveillance, 2000, Atlanta : CDC, 2001.
  • 5
    Levine WC et al., Indirect estimation of chlamydia screening coverage using public health surveillance data, American Journal of Public Health, 2004 (forthcoming).
  • 6
    Groseclose SL et al., Estimated incidence and prevalence of genital Chlamydia trachomatis infection in the United States, 1996, Sexually Transmitted Diseases, 1999, 26(6):339344.
  • 2
    7.CDC, Chlamydia Prevalence Monitoring Project Annual Report 2000: Sexually Transmitted Disease Surveillance 2000 Supplement, Atlanta : CDC, 2001.
  • 8
    Sonenstein FL et al. 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).
  • 9
    CDC, 2001, op. cit. (see reference 4).
  • 10
    Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
  • 11
    CDC, 2001, op. cit. (see reference 4).
  • 3
    12.Ibid.
  • 13
    Cates W, Jr., and American Social Health Association Panel, 1999, op. cit. (see reference 1).
  • 14
    Johnson R et al. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States, New England Journal of Medicine, 1989, 321 (1):712;
  • 4
    Fleming DT et al., Herpes simplex virus type 2 in the United States, 1976–1994, New England Journal of Medicine, 1997, 337 (16): 11051111; Armstrong G et al., Incidence of herpes simplex virus type 2 infection in the United States, American Journal of Epidemiology, 2001, 153(9):912–920; and Fisman DN et al., Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States, Sexually Transmitted Diseases, 2002, 29(10):608–622.
  • 15
    CDC, 2001, op. cit. (see reference 4).
  • 16
    Tao G, Kassler W and Rein D, Medical care expenditures for genital herpes in the United States, Sexually Transmitted Diseases, 2000, 27 (1):3238; and.
  • 5
    Corey L and Wald A, Genital herpes, in:HolmesKK et al., eds., Sexually Transmitted Diseases, New York : McGraw-Hill, 1999, pp. 285312.
  • 17
    Corey L and Handsfield H, Genital herpes and public health: addressing a global problem, Journal of the American Medical Association, 2000, 283 (6):791794.
  • 18
    Fleming DT et al. 1997, op. cit. (see reference 14).
  • 19
    Armstrong G et al, 2001, op. cit. (see reference 14).
  • 20
    Ibid.
  • 21
    Myers ER, Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis, American Journal Epidemiology, 2000, 151 (12):11581171.
  • 22
    Bauer HM et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method, Journal of the American Medical Association, 1991, 265 (4):472477.
  • 23
    Coleman PJ et al. Incidence of hepatitis B virus infection in the United States, 1976–1994: estimates from the National Health and Nutrition Examination Surveys, Journal of Infectious Diseases, 1998, 178 (4): 954959.
  • 24
    Armstrong G, CDC, Atlanta, personal communication, Sept. 9 2003.
  • 25
    Goldstein ST et al. Incidence and risk factors for acute hepatitis B in the United States, 1982–1998: implications for vaccination programs, Journal of Infectious Diseases, 2002, 185 (6):713719.
  • 26
    Margolis HS et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations, Journal of the American Medical Association, 1995, 274 (15):12011208.
  • 27
    World Health Organization (WHO), Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates, Geneva : WHO, 2001.
  • 28
    Krieger JN and Alderete JF, Trichomonas vaginalis and trichomoniasis, in: HolmesKK et al., 1999, op. cit. (see reference 16), pp. 587604.
  • 29
    WHO, 2001, op. cit. (see reference 27).
  • 30
    Lossick JG, Epidemiology of urogenital trichomoniasis, in: HonigbergBM, ed., Trichomonads Parasitic in Humans, New York : Springer-Verlag, 1989, pp. 311323; and Cotch MF et al., Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women, Obstetrics & Gynecology, 1991, 78(6):1087–1092.
  • 31
    Krieger JN and Alderete JF, 1999, op. cit. (see reference 28).
  • 32
    Karon JM et al., HIV in the United States at the turn of the century: an epidemic in transition, American Journal of Public Health, 2001 91(7): 10601068; and Karon JM et al., Prevalence of HIV infection in the United States, 1984 to 1992, Journal of the American Medical Association, 1996, 276(2):126–131.
  • 33
    CDC, HIV among young men who have sex with men, Morbidity and Mortality Weekly Report, 2001, 50 (21): 440444; and CDC, Primary and secondary syphilis–United States, 2002, Morbidity and Mortality Weekly Report, 2003, 52(46):1117–1120.
  • 34
    Rosenberg PS and Biggar RJ, Trends in HIV incidence among young adults in the United States, Journal of the American Medical Association, 1998, 279 (23):18941899.
  • 35
    Doyle TJ, Glynn MK and Groseclose SL, Completeness of notifiable infectious disease reporting in the United States: an analytical review, American Journal of Epidemiology, 2002, 155 (9):866874.
  • 36
    Frost JJ, Public or private providers? U.S. women's use of reproductive health services, Family Planning Perspectives, 2001, 33 (1):412.
  • 37
    Groseclose SL et al., 1999, op. cit. (see reference 6).
  • 38
    Sonenstein FL et al., 1998, op. cit. (see reference 2); Abma J et al., 1997, op. cit. (see reference 2); and Laumann EO et al., 1995, op. cit. (see reference 2).